Overcoming FVIII Inhibitors With Efanesoctocog Alfa – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Aqsa Ashraf et. al, adding:
“Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series
Two patients with severe hemophilia A and complex inhibitor histories underwent immune tolerance induction with efanesoctocog alfa at 100 U/kg three times weekly.
Inhibitor titers became undetectable within six weeks and three months, with FVIII recovery above 90%.
Once-weekly prophylaxis maintained troughs of 4-6% and bleed-free outcomes, allowing emicizumab discontinuation.”
Title: Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series
Authors: Aqsa Ashraf, Rebekah Kuhlman, Osman Khan, Sanober Nusrat

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal